{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T04:38:06Z","timestamp":1768797486673,"version":"3.49.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Barrett's oesophagus is a precursor to the development of oesophageal adenocarcinoma. This study sought to clarify the role of genetic, chromosomal and proliferation biomarkers that have been the subjects of multiple studies through meta-analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>MEDLINE, Embase, PubMed and the Cochrane Library were searched for clinical studies assessing the value of p53, p16, Ki-67 and DNA content abnormalities in Barrett's oesophagus. The main outcome measure was the risk of development of high-grade dysplasia (HGD) or oesophageal adenocarcinoma.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Some 102 studies, with 12 353 samples, were identified. Mutation (diagnostic odds ratio (DOR) 10\u00b791, sensitivity 47 per cent, specificity 92 per cent, positive likelihood ratio (PLR) 4\u00b771, negative likelihood ratio (NLR) 0\u00b765, area under the curve (AUC) 0\u00b7792) and loss (DOR 16\u00b716, sensitivity 31 per cent, specificity 98 per cent, PLR 6\u00b766, NLR 0\u00b741, AUC 0\u00b7923) of p53 were found to be superior to the other p53 abnormalities (loss of heterozygosity (LOH) and overexpression). Ki-67 had high sensitivity in identifying high-risk patients (DOR 5\u00b754, sensitivity 82 per cent, specificity 48 per cent, PLR 1\u00b759, NLR 0\u00b742, AUC 0\u00b7761). Aneuploidy (DOR 12\u00b708, sensitivity 53 per cent, specificity 87 per cent, PLR 4\u00b726, NLR 0\u00b742, AUC 0\u00b7846), tetraploidy (DOR 5\u00b787, sensitivity 46 per cent, specificity 85 per cent, PLR 3\u00b747, NLR 0\u00b765, AUC 0\u00b7793) and loss of Y chromosome (DOR 9\u00b723, sensitivity 68 per cent, specificity 80 per cent, PLR 2\u00b767, NLR 0\u00b749, AUC 0\u00b7807) also predicted malignant development, but p16 aberrations (hypermethylation, LOH, mutation and loss) failed to demonstrate any advantage over the other biomarkers studied.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Loss and mutation of p53, and raised level of Ki-67 predicted malignant progression in Barrett's oesophagus.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/bjs.10484","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T14:50:35Z","timestamp":1489503035000},"page":"493-502","source":"Crossref","is-referenced-by-count":30,"title":["Meta-analysis of biomarkers predicting risk of malignant progression in Barrett's oesophagus"],"prefix":"10.1093","volume":"104","author":[{"given":"K","family":"Altaf","sequence":"first","affiliation":[{"name":"Department of Surgery, Whiston Hospital, St Helen's and Knowsley Hospitals NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-J","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"De la Iglesia","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Hickey","sequence":"additional","affiliation":[{"name":"Department of Surgery, Whiston Hospital, St Helen's and Knowsley Hospitals NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Kaul","sequence":"additional","affiliation":[{"name":"Department of Surgery, Whiston Hospital, St Helen's and Knowsley Hospitals NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"2021020617274817800_bjs10484-bib-0001","first-page":"1035","article-title":"Barrett's esophagus: incidence, etiology, pathophysiology, prevention and treatment","volume":"3","author":"Modiano","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"2021020617274817800_bjs10484-bib-0002","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jnci\/djr203","article-title":"Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study","volume":"103","author":"Bhat","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2021020617274817800_bjs10484-bib-0003","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett's esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"N Engl J Med"},{"key":"2021020617274817800_bjs10484-bib-0004","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2559.2007.02706.x","article-title":"Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists","volume":"50","author":"Kerkhof","year":"2007","journal-title":"Histopathology"},{"key":"2021020617274817800_bjs10484-bib-0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0016-5107(99)70339-1","article-title":"Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice","volume":"50","author":"Alikhan","year":"1999","journal-title":"Gastrointest Endosc"},{"key":"2021020617274817800_bjs10484-bib-0006","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1365-2559.2010.03571.x","article-title":"A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase)","volume":"56","author":"Sonwalkar","year":"2010","journal-title":"Histopathology"},{"key":"2021020617274817800_bjs10484-bib-0007","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PAS.0b013e3181ffdd14","article-title":"Interobserver variability in the diagnosis of crypt dysplasia in Barrett esophagus","volume":"35","author":"Coco","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"2021020617274817800_bjs10484-bib-0008","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1158\/1078-0432.CCR-12-2880","article-title":"DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus","volume":"19","author":"Alvi","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2021020617274817800_bjs10484-bib-0009","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1038\/sj.onc.1208598","article-title":"Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk","volume":"24","author":"Schulmann","year":"2005","journal-title":"Oncogene"},{"key":"2021020617274817800_bjs10484-bib-0010","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/ajg.2009.300","article-title":"DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus","volume":"104","author":"Wang","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"2021020617274817800_bjs10484-bib-0011","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-138-3-200302040-00009","article-title":"Screening and surveillance for Barrett esophagus in high-risk groups: a cost\u2013utility analysis","volume":"138","author":"Inadomi","year":"2003","journal-title":"Ann Intern Med"},{"key":"2021020617274817800_bjs10484-bib-0012","first-page":"1193","article-title":"Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens","volume":"149","author":"Qian","year":"1996","journal-title":"Am J Pathol"},{"key":"2021020617274817800_bjs10484-bib-0013","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/j.1572-0241.2001.05261.x","article-title":"Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables","volume":"96","author":"Rabinovitch","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2021020617274817800_bjs10484-bib-0014","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/0016-5085(92)90758-Q","article-title":"Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort","volume":"102","author":"Reid","year":"1992","journal-title":"Gastroenterology"},{"key":"2021020617274817800_bjs10484-bib-0015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The diagnostic odds ratio: a single indicator of test performance","volume":"56","author":"Glas","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"2021020617274817800_bjs10484-bib-0016","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2021020617274817800_bjs10484-bib-0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"2021020617274817800_bjs10484-bib-0018","author":"Higgins","year":"2016","journal-title":"Cochrane Handbook of Systematic Reviews of Interventions, Version 5.0.2"},{"key":"2021020617274817800_bjs10484-bib-0019","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"key":"2021020617274817800_bjs10484-bib-0020","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"2021020617274817800_bjs10484-bib-0021","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2021020617274817800_bjs10484-bib-0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2021020617274817800_bjs10484-bib-0023","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0046-8177(94)90113-9","article-title":"p53 immunohistochemistry: a word of caution","volume":"25","author":"Battifora","year":"1994","journal-title":"Hum Pathol"},{"key":"2021020617274817800_bjs10484-bib-0024","first-page":"4784","article-title":"p53-mutant clones and field effects in Barrett's esophagus","volume":"59","author":"Prevo","year":"1999","journal-title":"Cancer Res"},{"key":"2021020617274817800_bjs10484-bib-0025","first-page":"846","article-title":"Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas","volume":"53","author":"Wagata","year":"1993","journal-title":"Cancer Res"},{"key":"2021020617274817800_bjs10484-bib-0026","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/0016-5085(94)90225-9","article-title":"TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus","volume":"107","author":"Hamelin","year":"1994","journal-title":"Gastroenterology"},{"key":"2021020617274817800_bjs10484-bib-0027","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0002-9610(94)90053-1","article-title":"Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer","volume":"167","author":"Casson","year":"1994","journal-title":"Am J Surg"},{"key":"2021020617274817800_bjs10484-bib-0028","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ijc.2910560406","article-title":"Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma","volume":"56","author":"Moore","year":"1994","journal-title":"Int J Cancer"},{"key":"2021020617274817800_bjs10484-bib-0029","first-page":"4211","article-title":"Molecular phenotype of spontaneously arising 4N (G2-tetraploid) intermediates of neoplastic progression in Barrett's esophagus","volume":"63","author":"Barrett","year":"2003","journal-title":"Cancer Res"},{"key":"2021020617274817800_bjs10484-bib-0030","first-page":"4033","article-title":"The evolution of loss of heterozygosity on chromosome 17 during the progression to Barrett's adenocarcinoma involves a unique combination of target sites in individual specimens","volume":"6","author":"Dunn","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2021020617274817800_bjs10484-bib-0031","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1572-0241.2003.07411.x","article-title":"Losses of heterozygosity on chromosomes 9p and 17p are frequent events in Barrett's metaplasia not associated with dysplasia or adenocarcinoma","volume":"98","author":"Suspiro","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2021020617274817800_bjs10484-bib-0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","article-title":"British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus","volume":"63","author":"Fitzgerald","year":"2014","journal-title":"Gut"},{"key":"2021020617274817800_bjs10484-bib-0033","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ajg.2015.55","article-title":"BOB CAT: a large-scale review and Delphi consensus for management of Barrett's esophagus with no dysplasia, indefinite for, or low-grade dysplasia","volume":"110","author":"Bennett","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2021020617274817800_bjs10484-bib-0034","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/sj.bjc.6603744","article-title":"Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia\u2013dysplasia\u2013adenocarcinoma sequence","volume":"96","author":"Griffiths","year":"2007","journal-title":"Br J Cancer"},{"key":"2021020617274817800_bjs10484-bib-0035","first-page":"962","article-title":"Apoptosis and cell proliferation in the metaplasia\u2013dysplasia\u2013carcinoma-sequence of Barrett's esophagus","volume":"47","author":"Halm","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"2021020617274817800_bjs10484-bib-0036","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2559.2005.02139.x","article-title":"Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus","volume":"46","author":"Lorinc","year":"2005","journal-title":"Histopathology"},{"key":"2021020617274817800_bjs10484-bib-0037","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/PAI.0b013e318168598b","article-title":"p16, cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus","volume":"16","author":"Shi","year":"2008","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2021020617274817800_bjs10484-bib-0038","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/j.1572-0241.2004.30886.x","article-title":"DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues","volume":"99","author":"Fang","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"2021020617274817800_bjs10484-bib-0039","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<641::AID-CNCR3>3.0.CO;2-N","article-title":"Flow cytometric DNA analysis and p53 protein expression show a good correlation with histologic findings in patients with Barrett's esophagus","volume":"83","author":"Gim\u00e9nez","year":"1998","journal-title":"Cancer"},{"key":"2021020617274817800_bjs10484-bib-0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/CBM-2008-4101","article-title":"Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus","volume":"4","author":"Kerkhof","year":"2008","journal-title":"Cancer Biomark"},{"key":"2021020617274817800_bjs10484-bib-0041","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/ajg.2009.437","article-title":"Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case\u2013control study","volume":"104","author":"Sikkema","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"2021020617274817800_bjs10484-bib-0042","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00008469-199612002-00009","article-title":"Barrett's esophagus: ordering the events that lead to cancer","volume":"5","author":"Reid","year":"1996","journal-title":"Eur J Cancer Prev"},{"key":"2021020617274817800_bjs10484-bib-0043","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1073\/pnas.93.14.7081","article-title":"17p (p53) allelic losses, 4N (G2\/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus","volume":"93","author":"Galipeau","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021020617274817800_bjs10484-bib-0044","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/8816","article-title":"Evolution of neoplastic cell lineages in Barrett oesophagus","volume":"22","author":"Barrett","year":"1999","journal-title":"Nat Genet"},{"key":"2021020617274817800_bjs10484-bib-0045","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/jnci\/91.24.2087","article-title":"Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue","volume":"91","author":"Galipeau","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2021020617274817800_bjs10484-bib-0046","first-page":"2292","article-title":"17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy","volume":"54","author":"Blount","year":"1994","journal-title":"Cancer Res"},{"key":"2021020617274817800_bjs10484-bib-0047","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1101\/gad.10.9.1054","article-title":"p53: puzzle and paradigm","volume":"10","author":"Ko","year":"1996","journal-title":"Genes Dev"},{"key":"2021020617274817800_bjs10484-bib-0048","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/78595","article-title":"Mice without telomerase: what can they teach us about human cancer?","volume":"6","author":"Artandi","year":"2000","journal-title":"Nat Med"},{"key":"2021020617274817800_bjs10484-bib-0049","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"2021020617274817800_bjs10484-bib-0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/11.1.1","article-title":"Proceedings from an international conference on ablation therapy for Barrett's mucosa. Brittany, France, 31 August\u20132 September 1997","volume":"11","author":"Bremner","year":"1998","journal-title":"Dis Esophagus"},{"key":"2021020617274817800_bjs10484-bib-0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(99)70437-2","article-title":"Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients","volume":"49","author":"Overholt","year":"1999","journal-title":"Gastrointest Endosc"},{"key":"2021020617274817800_bjs10484-bib-0052","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0016-5107(96)70004-4","article-title":"Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results","volume":"44","author":"Sampliner","year":"1996","journal-title":"Gastrointest Endosc"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbjs.10484","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/104\/5\/493\/36207442\/bjs10484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/104\/5\/493\/36207442\/bjs10484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T14:17:54Z","timestamp":1621520274000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/104\/5\/493-502\/6095104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,14]]},"published-print":{"date-parts":[[2017,3,14]]}},"URL":"https:\/\/doi.org\/10.1002\/bjs.10484","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,4]]},"published":{"date-parts":[[2017,3,14]]}}}